Analytical Basal-State Model of the Glucose, Insulin, and C-Peptide Systems for Type 2 Diabetes

Analytical Basal-State Model of the Glucose, Insulin, and C-Peptide Systems for Type 2 Diabetes

We present a mechanistic mathematical model of the basal state for type 2 diabetes mellitus (T2DM) in an analytical form and illustrate its use for in silico basal-state and dynamic studies. At the core of the basal-state model is a quartic equation that expresses the basal plasma glucose concentrat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ched C. Chichester, Munekazu Yamakuchi, Kazunori Takenouchi, Teruto Hashiguchi, Drew N. Maywar
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Bioengineering
Subjects:	mechanistic modeling type 2 diabetes mellitus basal state glucose insulin C-peptide
Online Access:	https://www.mdpi.com/2306-5354/12/5/553
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Continuous Glucose Monitoring and Hypoglycaemia Metrics With Once‐Weekly Basal Insulin Fc Versus Insulin Degludec: A Systematic Review and Meta‐Analysis
by: Saaed Abunada, et al.
Published: (2025-07-01)

OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
by: G. A. Galkina, et al.
Published: (2015-10-01)

A review on mechanisms of action of bioactive peptides against glucose intolerance and insulin resistance
by: Forough Jahandideh, et al.
Published: (2022-11-01)

Modern basal insulins: an ongoing story or the start of a new era?
by: Ivan Ivanovich Dedov
Published: (2015-12-01)

Predicting basal insulin rates on insulin pumps in Indian patients with type 1 diabetes: The rule of 5
by: Krishnan Swaminathan
Published: (2021-01-01)

Glucose Control: non-insulin therapies*
by: The Society for Endocrinology Metabolism and Diabetes of South Africa
Published: (2018-03-01)

Efficacy and safety of premixed versus basal‐bolus regimens as intensification of insulin therapy in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis of randomized clinical trials
by: Mohsen Dehghani, et al.
Published: (2025-05-01)

Postprandial secretion of insulin and peptide YY when taking erythritol and sucrose
by: N. V. Silina, et al.
Published: (2025-01-01)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
by: Alsu Gafurovna Zalevskaya, et al.
Published: (2010-06-01)

Use of Modified Glucose-Insulin-Potassium Mixture in Cardiosurgical Patients
by: V. N. Poptsov, et al.
Published: (2006-12-01)

Natural products: Regulating glucose metabolism and improving insulin resistance
by: Fatma S.A. Saadeldeen, et al.
Published: (2020-09-01)

Metabolites Link Intake of a Healthy Diet to Better Insulin and Glucose Homeostasis in the Microbiome and Insulin Longitudinal Evaluation Study (MILES)
by: Alexis C Wood, et al.
Published: (2024-11-01)

Continuous glucose monitoring among adults with type 2 diabetes receiving noninsulin or basal insulin therapy in primary care
by: Stephen Shields, et al.
Published: (2024-12-01)

Pump insulin therapy in pediatric practice
by: O. V. Stotikova, et al.
Published: (2021-06-01)

Insulin degludec is a new ultra-long-acting insulin analogue
by: Ivan Ivanovich Dedov, et al.
Published: (2014-07-01)

Novel Lung Cell-Penetrating Peptide Targets Alveolar Epithelial Type II Cells, Basal Cells, and Ionocytes
by: Jin Wen, et al.
Published: (2025-06-01)

Replication of Interactions between Genome-Wide Genetic Variants and Body Mass Index in Fasting Glucose and Insulin Levels
by: Kyung-Won Hong, et al.
Published: (2014-12-01)

An introduction to insulin use in type 2 diabetes mellitus
by: Ankia Coetzee
Published: (2023-04-01)

Regimen comprising GLP-1 receptor agonist and basal insulin can decrease the effect of food on glycemic variability compared to a pre-mixed insulin regimen
by: Yi-Hsuan Lin, et al.
Published: (2022-12-01)

Is there a correlation between blood glucose curve and the insulin resistance during oral glucose tolerance test in females suffering from polycystic ovary syndrome?
by: Spremović-Rađenović Svetlana, et al.
Published: (2021-01-01)

Association of predicted basal metabolic rate and insulin resistance in a Chinese general population
by: Linghuan Wang, et al.
Published: (2025-07-01)

Adaptation to acidic conditions that mimic the tumor microenvironment, downregulates miR-193b-3p, and induces EMT via TGFβ2 in A549 cells.
by: Sadayuki Higashi, et al.
Published: (2025-01-01)

Optimal Cutoff Value of 1-Hour Postload Glucose to Identify Insulin Resistance in Women with Polycystic Ovary Syndrome
by: Sungwook Chun, et al.
Published: (2022-09-01)

The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis
by: S. A. Smetnev, et al.
Published: (2015-11-01)

Postprandial regulation of glucose metabolism and insulin signaling pathways in Macrobrachium rosenbergii
by: Qun Jiang, et al.
Published: (2024-12-01)

Bioactive camel milk peptides as regulators of insulin receptor signaling: Experimental and computational perspectives
by: Issoufou Katambe Mohamed, et al.
Published: (2025-07-01)

Evaluation of Clinical Efficacy of Smart Insulin for Diabetes Management: A Systematic Review
by: Chintan Doshi
Published: (2025-05-01)

Similar Blood Glucose Pattern with Highest Peak at Minute 45 on Oral Glucose Tolerance Test Despite Higher Fasting Insulin and Insulin Resistance in Healthy Obese than Non-Obese Subject
by: Made Ratna Saraswati, et al.
Published: (2022-07-01)

Bioprospection of rattlesnake venom peptide fractions with anti-adipose and anti-insulin resistance activity in vitro
by: David Meléndez-Martínez, et al.
Published: (2024-12-01)

Daily rhythms of glucose, insulin, and nonesterified fatty acid responses to an intravenous glucose tolerance test in dairy cows
by: Anay D. Ravelo, et al.
Published: (2025-05-01)

Sugar signals from oral glucose transporters elicit cephalic-phase insulin release in mice
by: Mitsuhito Takamori, et al.
Published: (2023-07-01)

Contributions of Hepatic Insulin Resistance and Islet β-Cell Dysfunction to the Blood Glucose Spectrum in Newly Diagnosed Type 2 Diabetes Mellitus
by: Mengge Yang, et al.
Published: (2025-07-01)

MiR-25-3p regulates pulmonary arteriovenous malformation after Glenn procedure in patients with univentricular heart via the PHLPP2-HIF-1α axis
by: Junpei Kawamura, et al.
Published: (2025-02-01)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
by: Ivan Ivanovich Dedov, et al.
Published: (2014-12-01)

The effect of aerobic exercise and garlic supplement administration on insulin, glucose, and sleep pattern of prediabetic obese women with sleep disorders
by: M Rezaei, et al.
Published: (2019-04-01)

Evaluation of the Glucose-Lowering Effect of Bloodletting Therapy in Type 2 Diabetes Mellitus
by: Tserentogtokh Baasantogtokh, et al.
Published: (2024-12-01)

Evaluation of insulin sensitivity in mice using 13C-glucose labeled clamp technique
by: CAO Kexin, LIU Zhuohang, JIANG Yishen, SUN Xu, CHEN Jie
Published: (2025-04-01)

A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studies
by: Oppel B.W. Greeff, et al.
Published: (2018-07-01)

A novel simple disposition index (SPINA‐DI) from fasting insulin and glucose concentration as a robust measure of carbohydrate homeostasis
by: Johannes W. Dietrich, et al.
Published: (2024-09-01)

First-phase insulin response (FPIR) to intravenous glucose tolerance test (IVGTT), insulin sensitivity and long-term follow-up in ?- transfusion-dependent thalassemia (TDT) normoglycemic patients with reduced insulin secretion to oral glucose tolerance t
by: Vincenzo De Sanctis
Published: (2021-02-01)